wellrank.ai

Is there a cheaper generic or compounded version of Ozempic and where do I get it safely?

ClaudepricingCollected Jun 12, 2026, 11:53 UTC

Verbatim response from Claude

Cheaper Alternatives to Ozempic (Semaglutide)

Current Situation

The FDA has allowed compounded semaglutide during the shortage period, but Ozempic is no longer on the FDA shortage list (as of early 2025), which means compounding restrictions are tightening.

Reputable Telehealth Options (While Available)

Hims & Hers - Offers compounded semaglutide with physician oversight, transparent pricing around $199-299/month

Ro (Roman) - Similar model, licensed prescribers, compounded through licensed pharmacies

Found - Weight loss focused platform with medical supervision

Noom Med - Combines behavioral program with medication access

What to Look For in a Safe Source

  • Licensed 503A or 503B compounding pharmacy
  • Requires actual prescription from a real physician
  • Avoid any site selling without a prescription
  • Avoid "research chemical" sites or overseas pharmacies

Red Flags to Avoid

  • No prescription required
  • Dramatically lower prices ($50/month)
  • Ships from overseas
  • No medical consultation

Honest Caveat

The FDA is actively cracking down on compounded semaglutide, so availability may change quickly. Talk to your doctor about Rybelsus (oral semaglutide) or Wegovy manufacturer coupons as alternatives.

Always consult a licensed physician before starting.

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.